Tuesday, December 17, 2013 5:16:25 PM
Moreover, if European Approval for the expanded label happens, we should see 2.50 because if the EU approves Lymphoseek with the expanded label, it is an excellent bet that the FDA will do the same within 6 months in response to today's sNDA.
The turnaround is real...
GLTA.
Recent NAVB News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/06/2024 12:53:24 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM
VAYK Closes Acquisition of $1 Million Company • VAYK • Jan 30, 2025 9:52 AM
C2 Blockchain Inc. Secures Regulation A Approval, Prepares to Launch Bitcoin Mining Operations • CBLO • Jan 30, 2025 8:00 AM
Swifty Global Announces Signing of Share Purchase Agreement to be Acquired by Signing Day Sport (NYSE AMERICAN: SGN) • DRCR • Jan 29, 2025 11:19 AM